The global mosquito borne disease market is a rapidly growing market owing to the increasing prevalence of mosquito borne diseases like malaria, dengue, chikungunya, zika virus, yellow fever, and others across the world. Mosquito borne diseases are caused by viruses that are transmitted to humans through the bites of infected mosquitoes. Some key products available in the market include bed nets, coils, sprays, vaporizers creams and lotions that help in prevention and repellents against mosquitoes. The demand for rapid diagnostic devices for mosquito borne diseases is increasing to enable quick detection and treatment.

The Global mosquito borne disease market is estimated to be valued at US$ 3.59 Bn  in 2024 and is expected to exhibit a CAGR of 7.3% over the forecast period 2024 to 2030.

Key Takeaways

Key players operating in the Mosquito Borne Disease Market Size are Masimo, Medtronic Plc, Nihon-Kohden Corporation, GE Healthcare, Koninklijke Philips N.V., Hill-Rom Services, Inc.,Smiths Medical, Nonin, MICROTEK, OSI Systems, Inc. Honeywell International Inc., Promed Technology Co.Ltd., Beurer, Contec Medical Systems Co., Ltd., ChoiceMMed, CONMED Corporation, Stryker, Medline Industries, Inc., Curbell Medical Products, Inc., and Ecomed. The rising prevalence of mosquito borne diseases is fueling the demand for various detection and prevention products. Technological advancements are leading to the development of rapid point-of-care testing kits and more effective prevention products.

Market Trends
Personal protection products are gaining popularity- Products like wearables, apparels embedded with repellents are gaining traction. Devices that monitor the density of mosquitoes around are also being developed.

Remote monitoring is a key trend - Devices for remote monitoring of vital signs of patients affected by mosquito borne diseases enable effective supervision and early detection of complications. Devices integrated with AI and image recognition capabilities are being developed for rapid disease detection.

Market Opportunities
Launch of novel rapid testing kits - There is scope for development of easy-to-use strips or portable devices for quick diagnosis of mosquito borne diseases at point of care.

Rising access to healthcare in developing nations - With improvements in public health interventions, there lies opportunities to expand access to diagnosis and prevention products in emerging markets that report highest burden of these diseases.

Impact of COVID-19 on Mosquito Borne Disease Market

COVID-19 has had a significant impact on the mosquito borne disease market. The outbreak interrupted supply chains, slowed down production, and restricted transportation services globally. Healthcare resources were diverted towards treating COVID patients, which affected diagnosis and treatment of mosquito borne diseases like dengue, chikungunya and malaria. Social distancing norms and lockdowns also reduced outdoor activities thereby decreasing the chances of mosquito bites and spread of these diseases initially. However, post lockdown relaxation saw an increase in such diseases in 2021 as diagnosis and treatment services resumed gradually. Going forward, maintaining strict hygiene and preventing mosquito breeding will be crucial to control the spread of these diseases as countries learn to live with COVID. Telemedicine and home testing kits can help bridge gaps in healthcare access caused due to future waves of the pandemic. Governments need to focus on awareness programs regarding self care, social distancing and vector control while prioritizing treatment of outbreak prone diseases. Vaccination programs also need to be accelerated.

Asian and African countries see highest concentrations of Mosquito Borne Disease Market value. Densely populated countries in South Asia and sub-Saharan Africa have warm, humid climates conducive for mosquito breeding throughout the year. Countries like India, Brazil, Nigeria account for over 80% of malaria cases globally. Diagnosis and treatment services have significantly improved in these regions in recent years thanks to government initiatives, but investment in preventive healthcare will be important going ahead given the intermittent stresses on health systems from COVID waves. The market is also witnessing robust growth in Southeast Asian nations due to rising awareness, diagnostics and spending capacity. North American and European markets exhibit comparatively lower disease prevalence but higher per capita spends on advanced therapeutics and technologies for diagnosis.

The key fast growing region for the Mosquito Borne Disease Market will be Southeast Asia. Countries like Indonesia, Philippines, Vietnam and others in this tropical region have seen continuous rise in cases of dengue and malaria in the recent years due to rapid urbanization and climate change impacts. Limited healthcare infrastructure in many Southeast Asian nations had worsened the impact of COVID initially but governments are now investing strongly in building capacities. Factors like rising incomes, growing health awareness and increasing availability of diagnosis and treatment options will help drive higher spends on combating mosquito borne diseases from the region over the coming decade.

Get More Insights On This Topic: Mosquito Borne Disease Market